LAVAL, QC, March 16 /CNW Telbec/ - LAB Research Inc. (TSX: LRI) ("LAB
Research" or the "Company"), a rapidly growing non-clinical contract research
organization with operations in both North America and Europe, today announced
that Mr. Luc Mainville, President and CEO will be presenting at the 3rd Annual
Quebec Biotechnology Conference at the New York Society of Security Analysts,
March 20th, 2007 at 12:10pm EST. Analysts, portfolio managers, institutional
and venture capital investors, and other players from New York's financial
community will take part in this annual conference aimed at promoting a few of
Quebec's leading biotechnology firms.
About LAB Research Inc.
LAB Research is a non-clinical contract research organization (CRO) that
provides contract research services to the pharmaceutical, biotechnology and
agro-chemical market. LAB Research supports the development of its customers'
products from four state-of-the-art facilities located in Canada, the United
States, Denmark and Hungary. LAB Research's shares trade on the TSX under the
symbol "LRI" with 18.0 million shares outstanding.
For further information:
For further information: LAB Research Inc.: Luc Mainville, President and
Chief Executive Officer, (450) 973-2240, Ext.: 1206,
email@example.com; Media and Investor: Echoes Financial Network Inc.,
Dominic Sicotte, 866-633-9551, ext. 101, (514) 842-9551,